Kymera Therapeutics Inc (KYMR)
R&D Expenses
$119.48M
Quarterly · Period ending: · USD
KYMR R&D Expenses
Latest reported$119.48Mperiod ending
Latest reported$119.48Mperiod ending
KYMR Quarterly R&D Expenses ($11.31M → $119.48M)
Quarterly R&D Expenses
High-resolution chart · PNG
KYMR r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 119,481,000 | |
| 98,162,000 | |
| 83,863,000 | |
| 74,094,000 | |
| 78,388,000 | |
| 80,255,000 | |
| 71,817,000 | |
| 60,410,000 | |
| 59,202,000 | |
| 48,819,000 | |
| 52,970,000 | |
| 48,117,000 | |
| 45,767,000 | |
| 42,227,000 | |
| 43,133,000 | |
| 43,877,000 | |
| 41,293,000 | |
| 35,944,000 | |
| 37,530,000 | |
| 38,306,000 | |
| 35,220,000 | |
| 25,962,000 | |
| 20,392,000 | |
| 15,778,000 | |
| 13,819,000 | |
| 12,116,000 | |
| 11,086,000 | |
| 11,310,000 |